Cart
sales@molnova.com
Solasonine
CAS No. 19121-58-5
Solasonine( —— )
Catalog No. M18170 CAS No. 19121-58-5
The equimolar mixture Solamargine/Solasonine was the most active (IC50: 1.1 μM) after 72 h.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 72 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 201 | In Stock |
|
| 50MG | 294 | In Stock |
|
| 100MG | 435 | In Stock |
|
| 200MG | 637 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSolasonine
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe equimolar mixture Solamargine/Solasonine was the most active (IC50: 1.1 μM) after 72 h.
-
DescriptionThe equimolar mixture Solamargine/Solasonine was the most active (IC50: 1.1 μM) after 72 h.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number19121-58-5
-
Formula Weight884.07
-
Molecular FormulaC45H73NO16
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (113.11 mM)
-
SMILES[C@@H]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O[C@H]1[C@H]([C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5O[C@]6([C@H]([C@@H]5[C@]4(CC[C@@H]3[C@]2(CC1)C)C)C)NC[C@@H](CC6)C)CO)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fewell AM, et al. Interactions between the glycoalkaloids solasonine and solamargine in relation to inhibition of fungal growth. Phytochemistry. 1994 Nov;37(4):1007-11.
molnova catalog
related products
-
GSK-2838232
GSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.
-
MK-2048
MK-2048 is a potent inhibitor of HIV-1 integrase (IN) and IN mutant R263K with IC50 of 2.6 nM and 1.5 nM, respectively.
-
ST7612AA1
ST7612AA1 is a novel potent and oral HDCA inhibitor that acts as an HIV-1 latency reactivator. ST7612AA1 showed significant antitumor activity at low concentrations in vitro and in vivo.
